MAR 08, 2018 12:32 PM PST

How does brain cancer escape the immune system?

WRITTEN BY: Kara Marker

One of the most lethal forms of brain cancer owes most of its deadliness to its evasion of the immune system - a nasty trick that prevents T cells and other immune defenses from doing their job. In a new study from Brigham and Women’s Hospital, scientists learn a little bit more about how tumors play hide-and-seek with the immune system, potentially uncovering new ways to detect and treat brain cancer.

An MRI of a 15-year-old glioblastoma patient. Credit: Christaras A

Glioblastoma is a type of cancer that develops from astrocytes, supportive cells that live in the brain. This type of brain cancer is very malignant; tumor cells multiply quickly and tap several blood vessels for a steady supply of oxygen and nutrients. Glioblastoma tumors are usually found in the cerebral hemispheres of the brain and make up 15.4 percent of all primary brain tumors. Likelihood of developing glioblastoma increases with age, especially for men. The median survival for adults with glioblastoma is two or three years.

The new study focuses on extracellular vesicles (EVs), which glioblastoma tumor cells, like other cells, produce. EVs are known for their role in intercellular communication; cells often discard EVs as they undergo apoptosis, or programmed cell death. But in the case of brain cancer, tumor cells produce EVs to suppress the immune response.

EVs help tumors do so by providing a protein called PDL-1, which contributes to T cell deactivation. Cancer cells also “hijack” immune checkpoints to prevent the immune system from mounting an anti-cancer attack. EVs also contain DNA and RNA that help tumor cells not just survive, but flourish in the human body.

"This is the first time that anyone has observed that immune checkpoints can operate through extracellular vesicles and not just through the cell surface," explained co-corresponding author Sean Lawler, PhD. "This is a new concept, suggesting that these vesicles can work more distantly from the tumor cells."

In the study, researchers also found traces of DNA from EVs in the blood of glioblastoma patients, indicating EVs as a potential biomarker for the disease.

Researchers also analyzed blood samples from both healthy people and from glioblastoma patients. Out of 21 samples, researchers found elevated PDL-1 DNA in isolated EVs in 14 samples. The more PDL-1 DNA, the largest the tumors tended to be.

The findings of this study indicate a new opportunity for scientists to use EVs as a biomarker for glioblastoma, but studies with a larger group of participants are needed to confirm the significance of the results.

The present study was published in the journal Science Advances.

Sources: American Brain Tumor Association, Nature Reviews Drug Discovery, Brigham and Women’s Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 23, 2019
Immunology
AUG 23, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
OCT 22, 2019
Immunology
OCT 22, 2019
Immune System Responsible for Organ Failure in Malaria
In the most severe cases of malaria, a person can experience organ failure and die. Often times, though, this is not directly due to the parasitic malaria ...
OCT 31, 2019
Cancer
OCT 31, 2019
Unpacking lactate's role in the Warburg effect
In a recent issue of Nature, the findings of one study made a particularly big splash: how and why cancer cells use energy differently than healthy cells. ...
NOV 22, 2019
Immunology
NOV 22, 2019
Rogue Inflammation Activates Depression During Pregnancy
Unresolved inflammation in a pregnant woman’s body can lead to serious depression during and after pregnancy. A new study investigates the physiologi...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
Loading Comments...